Zemcelpro®: A New Hope for Patients with High-Risk Blood Cancers Revealed at EBMT 2026 ExCellThera's Zemcelpro® demonstrates remarkable survival rates for high-risk blood cancer patients, showcasing vital findings set for presentation at EBMT 2026.

Zemcelpro®: A New Hope for Patients with High-Risk Blood Cancers Revealed at EBMT 2026 #Canada #Montreal #ExCellThera #Zemcelpro® #Cordex_Biologics